Source: Annual Congress 2009 - Cell biology of lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
I. Barta, T. Kullmann, E. Csiszér, B. Antus (Budapest, Hungary). Changes in EBC cytokine pattern during treatment of COPD exacerbation. Eur Respir J 2009; 34: Suppl. 53, 2862

Member's Comments

No comment yet.

Related content which might interest you: Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Changes in the induced sputum proteome during COPD exacerbations Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020 Cytokines profile of blood and sputum in COPD exacerbation Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment Year: 2009 Cytokines profile of blood and sputum in COPD exacerbation Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Cytokine profile of blood and sputum in COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 575s Year: 2006 Variability in eosinophil levels at start of severe exacerbations of COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Sputum VEGF level increases with treatment of COPD acute exacerbation Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation Year: 2012 Analysis of cytokine gene expression after treatment and pulmonary rehabilitation of acute exacerbation in COPD Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Plasma biomarkers and response to therapy at exacerbation of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 39s Year: 2007 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Cytokine profile of blood and sputum at infectional COPD exacerbation Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Assessment of cytokine mRNA expression in patients with COPD exacerbations Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Characteristic of cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005 Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap Source: Eur Respir J 2014; 43: 421-429 Year: 2013 Changes of IL-6 level in bronchoalveolar fluid in patients with acute exacerbation of COPD before and after the treatment with tiotropium bromide, and its significance Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Adiponectin as a biomarker of systemic inflammatory response in stable and exacerbation phases of COPD Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 Cytokine receptors expression in induced sputum in asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 159s Year: 2001